澳大利亚队列中[68Ga]Ga-Pentixafor PET/CT鉴别醛固酮瘤
这项前瞻性初步研究在澳大利亚多民族人群中评估[68Ga]Ga-Pentixafor PET/CT作为肾上腺静脉取血(AVS)的无创替代方案,用于原发性醛固酮增多症分型。34例患者接受PET/CT和AVS,29例可分析,PET配体指数在AVS侧化组更高,PET/CT耐受性好且多数患者偏好。
要点
- 10分钟PET LI≥1.5特异性100%、敏感性50%识别醛固酮瘤。
- 40分钟PET LI≥1.4敏感性64%、特异性87%。
- PET/CT被28/29例患者认为更快、耐受更好且更偏好。
核心结论
- [68Ga]Ga-Pentixafor PET/CT耐受性好,作为原发性醛固酮增多症分型的无创工具具有前景,识别醛固酮瘤特异性高、敏感性中等。
研究设计与样本
- 前瞻性初步研究,招募CT可见肾上腺腺瘤的原发性醛固酮增多症成人患者,比较[68Ga]Ga-Pentixafor PET/CT与AVS。
主要发现
- 34例患者(中位年龄60岁)接受PET/CT和AVS,5例被排除,基于AVS分析15例双侧和14例单侧(9左侧、5右侧)病例。
- AVS侧化组10分钟PET LI中位数1.4(IQR 1.3-2.0),非侧化组1.1(IQR 1.1-1.3),P=0.014;40分钟分别为1.5(IQR 1.3-1.8)和1.1(IQR 1.0-1.2),P=0.014。
- 10分钟PET LI 1.5的敏感性50%、特异性100%;40分钟PET LI 1.4的敏感性64%、特异性87%。
- 调查显示PET/CT更快、耐受更好,28/29例参与者首选PET/CT。
关键数值与推荐
- 单侧病变定义为AVS促肾上腺皮质激素刺激前后侧化指数(LI)≥4,并经肾上腺切除术后生化反应确认。
- PET LI基于注射示踪剂后10和40分钟的SUVmax计算。
临床怎么用
- 对于CT可见肾上腺腺瘤的原发性醛固酮增多症患者,[68Ga]Ga-Pentixafor PET/CT可作为无创分型候选工具,高特异性有助于确认醛固酮瘤,但中等敏感性需结合临床。
局限性
- 初步研究样本量小,部分患者因AVS不完整或刺激前后LI不一致被排除,结果需更大规模验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary aldosteronism (PA) is the leading endocrine cause of hypertension. Subtyping is critical for identifying unilateral aldosterone-producing adenomas, which can be surgically resected. Adrenal vein sampling (AVS), the current standard for subtyping, is resource-intensive and invasive. We evaluated 68Ga-pentixafor PET/CT as a noninvasive nuclear imaging alternative to AVS, assessing its diagnostic accuracy and acceptability compared with AVS in a multiethnic population. Methods: This prospective pilot study recruited adults with PA and an adrenal adenoma visible on CT. Unilateral disease was defined by a lateralization index (LI) of greater than or equal to 4 on AVS, performed before and after adrenocorticotropic hormone stimulation, confirmed by biochemical response after adrenalectomy. The PET LI was calculated using the SUVmax at 10 and 40 min after tracer injection. Participants with incomplete AVS or discordance between LIs before and after adrenocorticotropic hormone stimulation were excluded from the comparison of AVS and PET unless they underwent adrenalectomy. Receiver-operating-characteristic curves were constructed to assess the performance of different PET LIs for predicting PA subtype compared with AVS or surgical outcome. Results: 68Ga-pentixafor PET/CT and AVS were performed in 34 patients (median age, 60 y). Five were excluded from the analysis, leaving 15 bilateral and 14 unilateral (9 left, 5 right) cases on the basis of AVS. The median PET LI at 10 min was 1.4 (interquartile range [IQR], 1.3-2.0) in the AVS-lateralized group and 1.1 (IQR, 1.1-1.3) in the nonlateralized group (P = 0.014); at 40 min, the median PET LI was 1.5 (IQR, 1.3-1.8) and 1.1 (IQR, 1.0-1.2), respectively (P = 0.014). A PET LI of 1.5 at 10 min achieved 100% specificity and 50% sensitivity. A PET LI of 1.4 at 40 min had higher sensitivity (64%) and lower specificity (87%). Survey responses indicated that PET/CT was faster, better tolerated, and the preferred test by 28 of 29 participants. Conclusion: 68Ga-pentixafor PET/CT is well-tolerated and promising as a noninvasive tool for PA subtyping, demonstrating high specificity and moderate sensitivity for identifying aldosterone-producing adenomas.
引用
- Ng E, Jong I, Lau KK, et al. Identification of Aldosterone-Producing Adrenal Adenomas Using [68Ga]Ga-Pentixafor PET/CT in an Australian Cohort. J Nucl Med. 2026. PMID: 41611475. doi:10.2967/jnumed.125.271006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。